Canada - English - Health Canada

apotex inc - loratadine - capsule - 10mg - loratadine 10mg - second generation antihistamines

Canada - English - Health Canada

catalent ontario limited - loratadine - capsule - 10mg - loratadine 10mg - second generation antihistamines

Canada - English - Health Canada

mylan pharmaceuticals ulc - loratadine - tablet - 10mg - loratadine 10mg - second generation antihistamines

Israel - English - Ministry of Health

bayer israel ltd - loratadine; pseudoephedrine sulfate - tablets prolonged release - loratadine 5 mg; pseudoephedrine sulfate 120 mg - loratadine - loratadine - relief of symptoms of seasonal allergic rhinitis when both the antihistaminic properties and the nasal decongestant activity are desired.

United States - English - NLM (National Library of Medicine)

bionpharma inc. - desloratadine (unii: fvf865388r) (desloratadine - unii:fvf865388r) - desloratadine tablets are indicated for the relief of the nasal and non-nasal symptoms of seasonal allergic rhinitis in patients 12 years of age and older. desloratadine tablets are indicated for the relief of the nasal and non-nasal symptoms of perennial allergic rhinitis in patients 12 years of age and older. desloratadine tablets are indicated for the symptomatic relief of pruritus, reduction in the number of hives, and size of hives, in patients with chronic idiopathic urticaria 12 years of age and older. desloratadine tablets are contraindicated in patients who are hypersensitive to this medication or to any of its ingredients or to loratadine [see warnings and precautions (5.1) and adverse reactions ( 6.2)]. risk summary the limited available data with desloratadine in pregnant women are not sufficient to inform a drug-associated risk for major birth defects and miscarriage. there are no adequate and well-controlled studies in pregnant women. desloratadine given during organogenesis to pregnant rats was

Australia - English - Department of Health (Therapeutic Goods Administration)

adiramedica pty ltd - desloratadine, quantity: 0.5 mg/ml - oral liquid, syrup - excipient ingredients: glycerol; propylene glycol; disodium edetate; sunset yellow fcf; sodium benzoate; citric acid monohydrate; sodium citrate; sucrose; purified water; flavour - desloratadine syrup is indicated for: - relief from hayfever, year-round allergies and hives. - relief of symptoms including sneezing, runny or itchy nose, itchy or watery eyes, itchy palate, itchy skin and hives.

Israel - English - Ministry of Health

trima israel pharmaceutical products maabarot ltd - desloratadine - syrup - desloratadine 0.5 mg/ml - desloratadine - for the relief of symptoms associated with allergic rhinitis and/or chronic idiopathic urticaria in adults and children 1 year of age and above.

United States - English - NLM (National Library of Medicine)

sandoz inc - desloratadine (unii: fvf865388r) (desloratadine - unii:fvf865388r) - desloratadine 5 mg

United States - English - NLM (National Library of Medicine)

paddock laboratories, llc - desloratadine (unii: fvf865388r) (desloratadine - unii:fvf865388r) - desloratadine 5 mg

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - loratadine, quantity: 10 mg - tablet, uncoated - excipient ingredients: colloidal anhydrous silica; sodium lauryl sulfate; maize starch; magnesium stearate; sodium starch glycollate type a; lactose monohydrate - for the treatment of seasonal and perennial allergic rhinitis and relief of symptoms and signs of chronic urticaria in adults and children 12 years of age and older.